Net income (loss) [USD, thousands]

Depreciation and amortization [USD, thousands]

Stock-based compensation [USD, thousands]

Restructuring equity modification expense [USD, thousands]

Accretion of discount or amortization of premium on investments [USD, thousands]

Amortization of debt issuance costs [USD, thousands]

Loss on fixed asset disposal [USD, thousands]

Induced conversion expense related to convertible notes [USD, thousands]

Deferred tax expense [USD, thousands]

Revaluation of acquisition-related contingent consideration liability [USD, thousands]

Net cash provided by (used in) operating activities [USD, thousands]

Purchases of investments [USD, thousands]

Proceeds from sales of investments [USD, thousands]

Proceeds from maturities of investments [USD, thousands]

Proceeds from sale of property and equipment [USD, thousands]

Purchases of intangible assets [USD, thousands]

Purchases of property and equipment [USD, thousands]

Business acquisitions, net of cash acquired [USD, thousands]

Net cash provided by (used in) investing activities [USD, thousands]

Proceeds from exercise of stock options and employee stock purchase plan [USD, thousands]

Payment of 2019 Notes [USD, thousands]

Payment of acquisition-related contingent consideration [USD, thousands]

Net cash provided by (used in) financing activities [USD, thousands]

Effect of exchange rate changes on cash and cash equivalents [USD, thousands]

Net increase (decrease) in cash and cash equivalents [USD, thousands]

Cash paid for interest [USD, thousands]

Purchases of property and equipment not yet paid [USD, thousands]

Accounts receivable [USD, thousands]

Inventory [USD, thousands]

Prepaid expenses and other assets [USD, thousands]

Accounts payable [USD, thousands]

Accrued compensation and employee related benefits [USD, thousands]

Accrued and other liabilities [USD, thousands]

Acquisition-related contingent consideration liability [USD, thousands]

Operating lease right-of-use assets [USD, thousands]

Operating lease liabilities [USD, thousands]

Deferred revenue [USD, thousands]

Cash and cash equivalents, Beginning of period [USD, thousands]

Cash and cash equivalents, End of period [USD, thousands]

Operating lease liabilities arising from obtaining ROU assets [USD, thousands]

Lease liabilities arising from remeasurement of ROU assets [USD, thousands]

26,396 shares of common stock issued for Voyantic Oy acquisition [USD, thousands]

7aa7234b4ea618d27ea694dbf1cac3896443b25a5185a4c4ba94fcb572bc15ca

Cash and cash equivalents (USD, thousands)

Short-term investments (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventory (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Long-term investments (USD, thousands)

Property and equipment, net (USD, thousands)

Operating lease right-of-use assets (USD, thousands)

Other non-current assets (USD, thousands)

Goodwill (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued compensation and employee related benefits (USD, thousands)

Accrued and other current liabilities (USD, thousands)

Current portion of operating lease liabilities (USD, thousands)

Current portion of long-term debt (USD, thousands)

Current portion of deferred revenue (USD, thousands)

Total current liabilities (USD, thousands)

Long-term debt, net of current portion (USD, thousands)

Operating lease liabilities, net of current portion (USD, thousands)

Deferred revenue, net of current portion (USD, thousands)

Total liabilities (USD, thousands)

Common stock (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated other comprehensive loss (USD, thousands)

Accumulated deficit (USD, thousands)

Total stockholders' equity (deficit) (USD, thousands)

Total liabilities and stockholders' equity (deficit) (USD, thousands)

3cd760900ce5bdce054445971fbce225289a1c7b5ebdcdbd825f67f90046f39f

Revenue (USD, thousands)

Cost of Revenue (USD, thousands)

Gross Profit (USD, thousands)

Research and Development Expenses (USD, thousands)

Sales and Marketing Expenses (USD, thousands)

General and Administrative Expenses (USD, thousands)

Amortization of Intangibles (USD, thousands)

Restructuring Costs (USD, thousands)

Total Operating Expenses (USD, thousands)

Loss from Operations (USD, thousands)

Other Income, Net (USD, thousands)

Income from Settlement of Litigation (USD, thousands)

Interest Expense (USD, thousands)

Income (Loss) Before Income Taxes (USD, thousands)

Income Tax Benefit (Expense) (USD, thousands)

Net Income (Loss) (USD, thousands)

Net Income (Loss) per Share - Basic (USD)

Net Income (Loss) per Share - Diluted (USD)

Weighted-Average Shares Outstanding - Basic (thousands)

Weighted-Average Shares Outstanding - Diluted (thousands)

45001d93007e31265f0b3faec251b8f5e5cad543b8062d07f742b6d97c0defc4

0fc648522605afe9d05d99efdf0112f90342c73dc4867cce819c1c6caf852347

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

cb20877d90663fd5cee4e3f03ec3c6c6d7d2ccd42e52d6e2ff369fe35ac36f38

Total Revenue (USD, thousands)

Cost of Goods Sold (COGS) (USD, thousands)

SG&A (USD, thousands)

Research and Development (R&D) (USD, thousands)

Depreciation and Amortization (D&A) (USD, thousands)

Operating Income (EBIT) (USD, thousands)

Net Income (USD, thousands)

EPS - Basic (USD)

EPS - Diluted (USD)

5199fa6cab2e6513329d32993597544bf48f1edd6342d92f7b172f1db350e40d

Americas

- United States

Asia Pacific

- China and Hong Kong

- Malaysia

EMEA

Europe, Middle East, Africa

Total Revenue

2453b878a3fec8dcf938768849cafdaf94091cbc5a383be8436f1735512ce71f

Endpoint ICs

Systems

- Product Revenue

- Development, Service, Licensing

4eac880663296176509fa87ec18ea80f65dbf07f4477d579e4a63a29445eae8d

IMPINJ (PI)

Financials